EDITORIAL
Published on 11 Mar 2021
Editorial: Dopaminergic Alterations in Schizophrenia
doi 10.3389/fnins.2021.663245
- 2,003 views
- 3 citations
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Dopaminergic Alterations in Schizophrenia
Dopaminergic Alterations in Schizophrenia
35k
Total Downloads
218k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 20 Jan 2021
PDE10A Inhibitors—Clinical Failure or Window Into Antipsychotic Drug Action?
doi 10.3389/fnins.2020.600178
- 12,283 views
- 29 citations
SYSTEMATIC REVIEW
Published on 09 Oct 2020
Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
doi 10.3389/fnins.2020.531763
- 20,677 views
- 53 citations
REVIEW
Published on 14 Jul 2020
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
doi 10.3389/fphar.2020.01003
- 87,499 views
- 171 citations
ORIGINAL RESEARCH
Published on 07 Jul 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
doi 10.3389/fphar.2020.01005
- 4,289 views
- 20 citations
REVIEW
Published on 30 Jun 2020
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
doi 10.3389/fpsyt.2020.00613
- 18,449 views
- 96 citations
REVIEW
Published on 23 Jun 2020
Disrupted Sleep and Circadian Rhythms in Schizophrenia and Their Interaction With Dopamine Signaling
doi 10.3389/fnins.2020.00636
- 14,718 views
- 62 citations
REVIEW
Published on 18 Jun 2020
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
doi 10.3389/fnins.2020.00632
- 11,536 views
- 21 citations
REVIEW
Published on 03 Jun 2020
Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models
doi 10.3389/fnins.2020.00542
- 15,322 views
- 46 citations
BRIEF RESEARCH REPORT
Published on 20 May 2020
Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
doi 10.3389/fnins.2020.00484
- 4,557 views
- 17 citations
REVIEW
Published on 31 Mar 2020
The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
doi 10.3389/fphar.2020.00394
- 14,037 views
- 68 citations
Published in
Frontiers in Neuroscience
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- Schizophrenia
- 3.2 impact factor
- 6.2 citescore
Impact
- 218kTopic views
- 180kArticle views
- 35kArticle downloads